Obesity and pancreatic cancer: possible role of the PI3K/Akt pathway.
Huang
Xu-Feng
XF
Chen
Jiezhong
J
D000730:Androstadienes / Q000627:therapeutic use*; D000818:Animals; D002455:Cell Division; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D020738:Leptin / Q000172:deficiency / Q000502:physiology; D051379:Mice; D009765:Obesity / Q000150:complications* / Q000201:enzymology / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D000077191:Wortmannin
D000730:Androstadienes; D004791:Enzyme Inhibitors; D020738:Leptin; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051057:Proto-Oncogene Proteins c-akt; D000077191:Wortmannin